Taking reported properties of RVX208 into consideration, our study indicated that RVX208 was an efficient inhibitor of BRD4 and contributed in reducing the inflammatory response and protecting monolayer of ECs, making it a potential therapeutic approach for the treatment of atherosclerosis and other inflammatory diseases (Figure 8). The gene discussed is BRD4; the disease is atherosclerosis.